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Syringe sharing among people who inject drugs (PWID) continues to be a major driver of the global HIV/AIDS pandemic. Globally, an estimated 1 in 10 new HIV infections is caused by injection drug use \[[@CR1]\]. The World Health Organization and other United Nations agencies consider needle and syringe programs (NSPs) to be a crucial component of HIV prevention efforts among PWID \[[@CR2]\]. However, in Thailand, despite endorsement of NSPs by public health authorities, such programs continue to be regarded as illegal \[[@CR3]\], resulting in NSP coverage as low as \<1 % among PWID in Thailand \[[@CR4]\].

Despite the legal controversy regarding NSPs, efforts are currently underway to enhance access to sterile syringes and promote secondary prevention among HIV-positive PWID in Thailand, including the provision of sterile syringes within drop-in centers for PWID that are operated by civil society and international organizations \[[@CR5]\]. In light of these efforts, we investigated the prevalence and correlates of syringe lending among a community-recruited sample of HIV-positive PWID in Bangkok, Thailand.
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The Mitsampan Community Research Project is a collaborative research project involving the Mitsampan Harm Reduction Center (Bangkok, Thailand), the Thai AIDS Treatment Action Group (Bangkok, Thailand), Chulalongkorn University (Bangkok, Thailand), and the British Columbia Centre for Excellence in HIV/AIDS/University of British Columbia (Vancouver, Canada). Between June 2009 and October 2011, the research partners undertook a serial cross-sectional study involving 650 unique community-recruited PWID. Potential participants were recruited through peer outreach and word of mouth and were invited to attend the Mitsampan Harm Reduction Center or O-Zone House (local drop-in centers for people who use drugs) to be part of the study. Adults residing in Bangkok or adjacent provinces who had injected drug(s) in the previous 6 months were eligible for participation in the study. All participants provided oral informed consent and completed an interviewer-administered questionnaire eliciting demographic data as well as information about drug use patterns, HIV risk behavior, and experiences with healthcare services. Participants received a stipend of 350 Thai Baht (approximately \$11 USD) upon completion of the questionnaire. The study was approved by the research ethics boards at Chulalongkorn University and the University of British Columbia.

The present analysis was restricted to PWID who reported being HIV-positive. The primary outcome of interest was reporting syringe lending in the 6 months prior to the time of interview, as defined by responding "Yes" to the question: "Have you lent your used needles/syringes to someone else in the last six months?" We compared the demographic, behavioral, and social/structural characteristics of PWID who did and did not report syringe lending using Pearson's *X*^2^ test and Fisher's exact test (when one or more cells contained values less than or equal to five). Variables considered included the following: median age (\<38 years vs. ≥38 years), gender (male vs. female), education level (\<secondary education vs. ≥secondary education), incarceration (yes vs. no), frequent heroin injection (≥daily vs. \<daily), frequent methamphetamine injection (≥daily vs. \<daily), frequent midazolam injection (≥daily vs. \<daily), binge drug use (yes vs. no), use of drugs in combination (yes vs. no), injecting with others on a frequent basis (≥25 % of the time vs. \<25 % of the time), enrollment in voluntary drug treatment (including methadone treatment) (yes vs. no), reporting difficulty accessing sterile syringes (yes vs. no), and receiving antiretroviral therapy (ART) at the time of interview (receiving vs. not receiving). All behavioral variables refer to the previous 6 months unless otherwise indicated. All *p* values were two-sided.
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A total of 650 unique individuals were seen during the study period, of which 127 (19.5 %) HIV-positive individuals with complete data were eligible for this study. Among the 127 individuals included in this study, 25 (19.7 %) were female. The median age was 38 years (interquartile range, 34--43 years). In total, 21 (16.5 %) participants reported that they had lent a used syringe to another person within the 6 months prior to their interview. As indicated in Table [1](#Tab1){ref-type="table"}, factors significantly and positively associated with syringe lending in bivariable analyses included the following: daily methamphetamine injection (odds ratio (OR) = 10.20, 95 % CI, 2.08--53.60), daily midazolam injection (OR = 3.14, 95 % CI, 1.13--8.72), use of drugs in combination (OR = 4.49, 95 % CI, 0.98--41.60), injecting with others on a frequent basis (OR = 4.25, 95 % CI, 1.26--18.30), and not receiving ART (OR = 2.93, 95 % CI, 1.09--7.86).Table 1Bivariable analysis of factors associated with syringe lending among a community-recruited sample of HIV-positive PWID in Bangkok, Thailand (*n* = 127)CharacteristicSyringe lending^a^Odds ratio (95 % CI)*p* valueYes 21 (16.5 %)No 106 (83.5 %)Age  \<38 years11 (52.4)52 (49.1)1.14 (0.45--2.92)0.781  ≥38 years10 (47.6)54 (50.9)Gender  Male19 (90.5)83 (78.3)0.38 (0.04--1.78)0.246  Female2 (9.5)23 (21.7)Education level  \<Secondary education11 (52.4)42 (39.6)1.68 (0.65--4.29)0.279  ≥Secondary education10 (47.6)64 (60.4)Incarceration^a^  Yes3 (14.3)13 (12.3)1.19 (0.20--4.99)0.728  No18 (85.7)93 (87.7)Heroin injection frequency^a^  ≥Daily2 (9.5)15 (14.2)0.64 (0.07--3.14)0.736  \<Daily19 (90.5)91 (85.8)Methamphetamine injection frequency^a^  ≥Daily6 (28.6)4 (3.8)10.20 (2.08--53.59)0.001  \<Daily15 (71.4)102 (96.2)Midazolam injection frequency^a^  ≥Daily15 (71.4)47 (44.3)3.14 (1.13--8.72)0.023  \<Daily6 (28.6)59 (55.7)Binge drug use^a^  Yes11 (52.4)34 (32.1)2.33 (0.90--6.01)0.076  No10 (47.6)72 (67.9)Use of drugs in combination^a^  Yes19 (90.5)72 (67.9)4.49 (0.98--41.55)0.037  No2 (9.5)34 (32.1)Injected with others on a frequent basis^a^  ≥25 % of the time17 (81.0)53 (50.0)4.25 (1.26--18.33)0.015  \<25 % of the time4 (19.0)53 (50.0)Enrolled in voluntary drug treatment (including methadone)^a^  Yes8 (38.1)38 (35.8)1.10 (0.42--2.89)0.845  No13 (61.9)68 (64.2)Difficulty accessing sterile syringes^a^  Yes0 (0.0)5 (4.7)0.590  No21 (100.0)101 (95.3)Receiving antiretroviral therapy^b^  Receiving7 (33.3)63 (59.4)  Not receiving14 (66.7)43 (40.6)2.93 (1.09--7.86)0.028*PWID* people who inject drugs^a^Denotes events/activities during the 6 months prior to the interview^b^Denotes events/activities at the time of the interview
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A high prevalence of used syringe lending was observed among our sample of HIV-positive PWID in Bangkok, with 16.5 % of participants reporting syringe lending in the past 6 months. Individuals who reported syringe lending were more likely to report high intensity drug use (i.e., daily injection of methamphetamine or midazolam), polysubstance use, frequently injecting with others, and not receiving ART.

It is particularly concerning that individuals who lent syringes were more likely to be untreated for HIV, given the known benefits of ART in preventing HIV transmission \[[@CR6]\]. This finding may suggest that individuals receiving ART may have greater access to NSPs and/or education on safer injecting practices secondary to their engagement in HIV care, compared to PWID not receiving ART, who may lack access to such education or services. Furthermore, HIV testing rates remain low in the Asia-Pacific region, with approximately 20 % of PWID having been previously tested \[[@CR7]\] and approximately 13 % of PWID avoiding HIV testing in one study in Thailand \[[@CR8]\]. Similarly, PWID in Thailand demonstrate considerably low rates of ART coverage, with only 2 % of HIV-positive PWID estimated to have ever accessed ART \[[@CR4]\], compared to a reported ART coverage rate of 65 % among all eligible people living with HIV in Thailand \[[@CR9]\]. Given Thailand's system of universal healthcare that provides ART for free or at a reduced cost \[[@CR10]\], the comparatively lower rates of ART uptake among PWID may be attributable to the Thai government's aggressive drug law enforcement strategies that may serve as barriers or deterrents for PWID to access health care \[[@CR11], [@CR12]\]. In this context, the lower odds of receiving ART among PWID who lent syringes in this study may suggest that aggressive enforcement may be shaping HIV risk behavior and ART uptake by discouraging access to HIV treatment and prevention programs. Therefore, targeted efforts to reduce the public health burden of aggressive drug law enforcement strategies (e.g., compulsory drug detention) within this setting should occur alongside initiatives to scale up evidence-based public health interventions including HIV testing, ART, peer-based HIV education, and NSPs, as described below \[[@CR13]\]. Strategies to address these gaps are currently underway in Thailand, including plans to provide ART irrespective of CD4 count and harmonize health insurance schemes for greater service deliver efficiency \[[@CR14]\]. Other interventions to enhance access to and implementation of early ART initiation should be also supported for HIV-positive PWID in Thailand. Finally, given the high prevalence (85--90 %) of HIV and hepatitis C (HCV) co-infection among PWID in Thailand \[[@CR15], [@CR16]\], as well as the greater transmissibility of HCV compared to HIV, these findings warrant further research on syringe lending behaviors among HCV-infected PWID and increased HCV testing, treatment, and education for PWID in Thailand.

The associations between syringe lending and high intensity drug use are consistent with previous literature on PWID in Thailand. Specifically, the association between daily methamphetamine injection and syringe lending in this study is consistent with a 2011 study that found that frequent methamphetamine injection was positively and independently associated with syringe sharing among Thai PWID \[[@CR17]\]. Additionally, previous studies have found associations between syringe sharing and polysubstance use \[[@CR18]\]. Given that midazolam is commonly used in combination with other drugs, the observed association between daily midazolam injection and syringe lending in this study may reflect the high prevalence of polysubstance use among midazolam injectors in Bangkok \[[@CR19], [@CR20]\]. Finally, our finding that syringe lending was associated with frequent injection with others complements previous associations found between frequent injection with others and syringe borrowing among Thai PWID \[[@CR21]\].

These findings add to the growing body of literature pointing to the high prevalence of risk behaviors for HIV and other infectious diseases (e.g., hepatitis C) among Thai PWID and the importance of harm reduction programs as an essential response to these epidemics \[[@CR22]\]. In particular, NSPs have been shown to dramatically reduce the prevalence of high-risk injection behaviors, as evidenced by a decrease in syringe sharing among PWID by more than 38 % due to the distribution of sterile injection equipment in one Canadian setting \[[@CR23]\]. Furthermore, NSPs have been shown to prevent HIV and hepatitis C transmission among PWID \[[@CR24]\]. Previous studies have highlighted the various difficulties that Thai PWID face in accessing sterile syringes, including distance from NSPs, limited pharmacy hours, and being refused syringes at pharmacies \[[@CR21]\]. In order to reduce the harms associated with injection drug use, particularly the risk of HIV and other infectious disease transmission, urgent action is needed to address these barriers and expand access to NSPs in Thailand.

This study has several limitations. First, due to the cross-sectional study design, we were unable to determine temporal relationships between the explanatory variables and the outcome. Thus, we are unable to infer causation from this observational study. Additionally, because we observed only 21 participants reporting syringe lending, we were unable to conduct multivariable analyses to examine the independent relationships between the explanatory variables and the outcome. Therefore, the associations observed in the present study should be further examined through multivariable, longitudinal analyses with a larger sample size. Third, the data collected were self-reported, including HIV serostatus, and may be subjected to reporting biases such as socially desirable reporting and recall bias. However, self-reported data are commonly used in observational studies involving PWID and have been repeatedly found to be valid \[[@CR25], [@CR26]\]. Nevertheless, it is possible that the use of self-reported serostatus in this study may confound the association between syringe lending and enrolment in antiretroviral therapy, such that individuals who are on ART may more accurately report their HIV serostatus compared to individuals not receiving ART, who may not have been formally tested for HIV. Fourth, given that the study sample was not randomly selected, the study findings may not be generalizable to Thai PWID or PWID in other settings. Finally, we did not collect data on number of injection partners; however, given past research highlighting the potential influence of social networks on syringe sharing behaviors among PWID \[[@CR24], [@CR27]\], this is an area that would benefit from further investigation.

In sum, 16.5 % of our sample of HIV-positive PWID in Bangkok reported used syringe lending in the 6 months prior to being interviewed. This high-risk behavior was associated with high intensity drug use, polysubstance use, injecting with others on a frequent basis, and not receiving ART. These findings emphasize the need to expand evidence-based public health interventions for HIV-positive PWID in Thailand, particularly through the expansion of early ART, NSPs, and peer-based HIV education.

AIDS

:   acquired immune deficiency syndrome

ART

:   antiretroviral therapy

CI

:   confidence interval

HIV

:   human immunodeficiency virus

PWID

:   people who inject drugs

NSP

:   needle and syringe program

OR

:   odds ratio

**Competing interests**

The authors declare that they have no competing interests.

**Authors' contributions**

PV, KH and TK designed the study. KH conducted the statistical analyses. PV drafted the manuscript and incorporated revisions from all co-authors. PV, KH, LT, KK, PS, EW, and TK made significant contributions to the conception of the analyses, interpretation of the data, and drafting of the manuscript. All authors read and approved the final manuscript.

We would particularly like to thank the study participants for their contribution to the research, as well as the staff and volunteers at the Mitsampan Harm Reduction Center, Thai AIDS Treatment Action Group, and O-Zone House for their support. We also thank Dr. Niyada Kiatying-Angsulee, Director of Social Research Institute, Chulalongkorn University, for her assistance with developing this project. We also thank Tricia Collingham, Deborah Graham, Caitlin Johnston, Calvin Lai, and Peter Vann for their research and administrative assistance and Prempreeda Pramoj Na Ayutthaya, Arphatsaporn Chaimongkon, Sattara Hattirat, and Puripakorn Pakdirat for their assistance with data collection.

Funding {#FPar1}
=======

The project was funded by the Michael Smith Foundation for Health Research. This research was also undertaken, in part, thanks to funding from the Canada Research Chairs program through a Tier 1 Canada Research Chair in Inner City Medicine which supports EW. KH is supported by a Canadian Institutes of Health Research Fellowship. PV is supported by the Canadian Institutes of Health Research.
